Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 144.35 | 147.47 |
| 52-Wk Range | - | - |
| Last Close | 145.24 |
| Mkt Cap (m) | 382,391.28 |
| Dividend yield | 2.70 |
| ISIN | US4781601046 |
| Volume | 4,154,372.00 |
| Exchange Venue | NYS |
Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Key Information
| Price/Earning | 22.84 |
| Price/Book | 6.07 |
| Price/Sales | 4.80 |
| P/CF | 18.71 |
| Rev Growth (3 year avg) | 4.51 |
| EPS Growth (3 year avg) | -0.02 |
| Operating Margin % | 24.47 |
| Net Margin % | 18.42 |
| Return on Equity | 25.36 |
| Debt/Equity | 0.47 |
Documents
Prospectus
| en 24/08/2020 |
Annual Report
| en 29/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 74,331.00 | 70,074.00 | 71,890.00 | 76,450.00 | 81,581.00 | 82,059.00 |
| Operating Income (m) | 20,959.00 | 18,065.00 | 21,136.00 | 18,714.00 | 20,049.00 | 20,080.00 |
| Net Income (m) | 16,323.00 | 15,409.00 | 16,540.00 | 1,300.00 | 15,297.00 | 15,119.00 |
| Basic EPS | 5.80 | 5.56 | 6.04 | 0.48 | 5.70 | 5.72 |
| Avg. Diluted Shares Outstanding (m) | 2,863.90 | 2,812.90 | 2,788.90 | 2,745.30 | 2,728.70 | 2,684.30 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 59,311.00 | 60,210.00 | 65,032.00 | 43,088.00 | 46,033.00 | 45,274.00 |
| Non Current Assets (m) | 71,808.00 | 73,201.00 | 76,176.00 | 114,215.00 | 106,921.00 | 112,454.00 |
| Total Assets (m) | 131,119.00 | 133,411.00 | 141,208.00 | 157,303.00 | 152,954.00 | 157,728.00 |
| Current Liabilities (m) | 25,085.00 | 27,747.00 | 26,287.00 | 30,537.00 | 31,230.00 | 35,964.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 69,752.00 | 71,150.00 | 70,418.00 | 60,160.00 | 59,752.00 | 59,471.00 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 18,471.00 | 19,279.00 | 18,767.00 | 21,056.00 | 22,201.00 | 23,416.00 |
| Capital Expenditure (m) | -3,714.00 | -3,463.00 | -3,226.00 | -3,279.00 | -3,670.00 | -3,498.00 |
Figures are quoted in USD unless stated otherwise
-
No change
$
145.24
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.